Cover Image
市場調查報告書

全球臨床診斷的自動化市場

Clinical Diagnostics Automation

出版商 Global Industry Analysts, Inc. 商品編碼 243081
出版日期 內容資訊 英文 275 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球臨床診斷的自動化市場 Clinical Diagnostics Automation
出版日期: 2014年05月01日 內容資訊: 英文 275 Pages
簡介

本報告提供全球臨床診斷的自動化市場相關調查,提供各產品,各地區的趨勢,今後的年度預測,及加入此市場的主要企業簡介等。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 臨床診斷實驗所對自動化態度的變化
    • 實驗室促進自動化的要素
    • 臨床診斷自動化的發展
    • 全球實驗室自動化市場上促進要素,趨勢,課題
    • 法律制度
    • 競爭
  • 市場趨勢,促進要素,課題
  • 臨床診斷自動化:概要
    • 實驗室自動化:流行
    • 實驗室自動化的優點
    • 臨床診斷自動化的簡介
    • 臨床診斷自動化的發展
    • 實驗室自動化系統的結構要素
    • 一般診斷實驗所結構
    • 實驗室的管理·資訊系統
    • 市場部門別臨床診斷自動化 其他
  • 產品引進/技術創新
  • 近幾年的產業活動
  • 全球參與企業
    • Abaxis, Inc.
    • Abbott Diagnostics, Inc.
    • Beckman Coulter, Inc.
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories, Inc.
    • Diagnostica Stago
    • Eppendorf AG (Germany)
    • F. Hoffmann-La Roche Ltd.
    • HORIBA ABX S.A.S.
    • Hudson Robotics, Inc.
    • Ortho Clinical Diagnostics, Inc.
    • PerkinElmer Inc.
    • QIAGEN NV
    • Siemens Healthcare Diagnostics, Inc.
    • Sysmex America, Inc.
    • Tecan Group Ltd.
    • The ELITechGroup SAS
    • Thermo Fisher Scientific, Inc.
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 其他
  • 南美
    • 巴西
    • 其他
  • 其他各國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6034

This report analyzes the worldwide markets for Clinical Diagnostics Automation in US$ Thousands by the following Product Segments: Automated Analyzers, Stand-alone Automation, and Total Lab Automation. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 57 companies including many key and niche players such as -

Abaxis, Inc.
Abbott Diagnostics, Inc.
Beckman Coulter, Inc.
Becton, Dickinson and Company
bioMerieux SA

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Market Segmentation
      • Automated Analyzers
      • Stand-Alone Automation
      • Total Laboratory Automation

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Changing Attitude towards Automation in Clinical Diagnostic Laboratories
  • Primary Factors Encouraging Laboratories to Embrace Automation - In A Nutshell
  • Automation - A Panacea to the Laboratories' Plight
  • The Road Ahead for Clinical Diagnostics Automation
  • Drivers, Trends and Challenges in the Global Lab Automation Market - At a Glance
  • Growth Drivers
  • Trends
  • Issues and Challenges
  • Despite Challenges, Emerging Markets Provide Growth Opportunities
  • Developed Nations: Cost Pressures Necessitate New Strategies
  • Regulatory Environment
  • Competition
    • Table 1: Leading Players in the Global Laboratory Automation Market (2011): Percentage Breakdown of Value Sales for Danaher, Eppendorf, Perkin Elmer, Tecan, Thermo and Others (includes corresponding Graph/Chart)

2. MARKET TRENDS, DRIVERS AND ISSUES

  • Need for High-Quality Healthcare Drives Demand for Clinical Diagnostics Automation
  • Rising Investments in Biotechnology - A Key Growth Driver
  • Clinical Diagnostics Automation - A Vital Tool in Patient Treatment Management
  • Need to Reduce Turnaround Times - A Major Growth Factor
  • Increasing Healthcare Spending in Emerging Markets - Opportunity for growth
    • Table 2: Healthcare Spending as % of GDP in Select Countries (2011) (includes corresponding Graph/Chart)
  • Healthcare Needs of Aging Population - An Important Opportunity Indicator
    • Table 3: Elderly Population (60+ Years) as a Percentage of Total Population (2012 & 2050) (includes corresponding Graph/Chart)
    • Table 4: Global Aging Population (60+) and their Proportion of Total Population (2012 & 2050) (includes corresponding Graph/Chart)
  • Rapid Detection of Infectious Diseases: Enhancing Need for Clinical Laboratory Automation Equipment
    • Table 5: Reported Cases of Major Infectious by Geographic Region (2011)
  • Rising Incidence of Cancer to Propels Demand for Clinical Diagnostics Automation
    • Table 6: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
    • Table 7: New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 8: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
    • Table 9: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers (includes corresponding Graph/Chart)
    • Table 10: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus and Liver Cancers (includes corresponding Graph/Chart)
    • Table 11: Global Cancer Mortality in Men for Select Cancers (2012): Number of Deaths in Thousands for Lung & Bronchus, Liver, Colorectal and Prostate Cancers (includes corresponding Graph/Chart)
    • Table 12: Global Cancer Mortality in Women for Select Cancers (2012): Number of Deaths in Thousands for Breast, Lung & Bronchus, Colorectal and Liver Cancer Prone Sites based on Age (includes corresponding Graph/Chart)
  • Cancer Prone Sites based on Age
  • End-User and Technology-Led Aspects Drive Demand for Automation
  • Automation - The Prime Solution to Enhance Laboratory Efficiency
  • Total Laboratory Automation - Only Good Enough for Large Hospitals
  • Large Hospitals See Good Return on Investments by TLA
  • Issues Continue to Plague Large Scale Automation Solutions
  • Bright Prospects Ahead for TLA
  • Modular Automation Surges Ahead of TLA in Adoption
  • Rising Demand for Automated Hematology Analyzers
  • Technological Advancements and Rising Awareness Levels Drive Growth in the Global Biochemistry Analyzers Market
  • Demand for POC Testing Rises
  • Automation Liberates Patients from Risk of Pre-analytical Diagnostic Errors
  • Blood Gas Analyzers - A Potential Solution to Reduce Time Lag Between Testing and Results
  • Point-of-care Testing - A Revolution in the Blood Gas and Electrolyte Analyzers Market
  • Automated Multiplexing Technology: Major Role in Clinical Diagnostics Automation
  • Multiplex Testing for Herpes Simplex Virus Type 1 and 2
  • Microbiology Labs: Growing Need for Automation
  • Automation to Provide Impetus to New Businesses
  • Internet Revolutionizes Laboratory Diagnostics
  • System Compatibility: A Key Requirement
  • Labor Shortage: A Key Challenge in the Clinical Lab Automation Market
  • Clinical Diagnostics Automation to Insulate Effects of Tightening Labor Market
  • Bar Code Technology Continues to Gain Adoption in Clinical Settings
  • Barcoding Eases Specimen and Consumable Identification
  • Bar Code Labeling Protects Patient Safety
  • Benefits of Barcoding to Medical Device Manufacturers
  • Laboratory Information System - A Key Aspect of Clinical Diagnostics Automation
  • Operational Concerns Associated with LIS

3. CLINICAL DIAGNOSTICS AUTOMATION - AN OVERVIEW

  • Laboratory Automation: Order of the Day
  • Benefits of Laboratory Automation
  • Introduction to Clinical Diagnostics Automation
  • Evolution of Clinical Diagnostics Automation
  • Components of Laboratory Automation System
  • Typical Diagnostic Laboratory Structure
  • Laboratory Control and Information System
  • Sample Storage
  • Sample Preparation
  • Transportation
  • Analysis
  • Clinical Diagnostics Automation by Market Segment
  • Automated Analyzers
  • Stand-Alone Automation
  • Total Laboratory Automation (TLA)
  • Limitations of TLA Systems
  • Modular Automation: Emerging Alternative
  • Total Laboratory Automation (TLA) Vs. Modular Laboratory Automation
  • Decentralized Testing Gains Importance
  • Advantages of POC Testing Over Centralized Laboratory Testing
  • Cost Analysis of POC Testing Vs. Laboratory Testing
  • Cost Savings through Space Savings
  • Major Components of Multi-Step Automation Process
  • Consolidation of Workstation
  • Information Management

4. PRODUCT INTRODUCTIONS/INNOVATIONS

  • Hamilton Unveils LabElite Range of Automated Benchtop Devices
  • Axiom Veterinary Laboratories Rolled out MiLab Range
  • Transasia Unveils Five New Automated Lab Instruments
  • Transasia Bio-Medicals Unveils Sysmex XN Series Differential Haematology Analyser
  • Immunetics Launches BacTx Analyzer for Use with BacTx Rapid Test
  • SIEMENS Launches VersaCell X3 Solution
  • Roche Launches cobas 8100 Automated Workflow Series
  • Roche Launches cobas(r) 6800 and cobas(r) 8800 Systems
  • Abbott Launches ACCELERATOR(r) a3600 Next Generation Automation Solution
  • Beckman Coulter Launches UniCel DxH 600 Benchtop Hematology Analyzer
  • Microscan Unveiled Auto ID and Machine Vision Technologies Line
  • Siemens Unveils Sysmex(r) CS-5100 System
  • Siemens Launches Aptio(tm) Automation
  • Roche Launches cobas p 312 Pre-Analytical System
  • Randox Unveils RX Daytona Compact Clinical Chemistry Analyser

5. RECENT INDUSTRY ACTIVITY

  • Carlyle Group to Acquire Ortho-Clinical Diagnostics
  • Singulex Partners with Tecan for Commercial Development of Ultrasensitive Sgx Clarity(tm) System
  • Roche and Hitachi Renew Development and Manufacturing Contract
  • Sysmex America Inks Distribution Agreement with Henry Schein
  • ERBA Diagnostics Receives FDA Approval for XL200 Clinical Chemistry Analyzer
  • Abaxis Receives Health Canada Class III Clearance for Piccolo Xpress(r)
  • NorDx to Acquire Sysmex(r) XN-Series Automated Hematology Analyzers
  • Francisco Partners Takes over McKesson's Hospital Automation Unit
  • Cerner Takes over Labotix Automation
  • Bio-Rad Enters into Development Agreement with Inpeco
  • CryoXtract(tm) Inks Distribution Agreement with Bio-Strategy Ltd
  • CML HealthCare Enters into Vendor Supply Agreement with Sysmex Canada
  • BD Completes Takeover of KIESTRA Lab Automation BV
  • Sysmex America Receives FDA Clearance of XN-Series Hematology Analyzers Products
  • IRIS International Inked Distribution Agreement with Alifax

6. FOCUS ON SELECT GLOBAL PLAYERS

  • Abaxis, Inc. (US)
  • Abbott Diagnostics, Inc. (US)
  • Beckman Coulter, Inc. (US)
  • Becton, Dickinson and Company (US)
  • bioMerieux SA (France)
  • Bio-Rad Laboratories, Inc. (US)
  • Diagnostica Stago (France)
  • Eppendorf AG (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • HORIBA ABX S.A.S. (France)
  • Hudson Robotics, Inc. (US)
  • Ortho Clinical Diagnostics, Inc. (US)
  • PerkinElmer Inc. (US)
  • QIAGEN NV (The Netherlands)
  • Siemens Healthcare Diagnostics, Inc. (US)
  • Sysmex America, Inc. (US)
  • Tecan Group Ltd. (Switzerland)
  • The ELITechGroup SAS (France)
  • Thermo Fisher Scientific, Inc. (US)

7. GLOBAL MARKET PERSPECTIVE

    • Table 13: World Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 14: World Historic Review for Clinical Diagnostics Automation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 15: World 15-Year Perspective for Clinical Diagnostics Automation by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 16: World Recent Past, Current and Future Analysis for Automated Analyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 17: World Historic Review for Automated Analyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 18: World 15-Year Perspective for Automated Analyzers by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 19: World Recent Past, Current and Future Analysis for Total Lab Automation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 20: World Historic Review for Total Lab Automation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 21: World 15-Year Perspective for Total Lab Automation by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 22: World Recent Past, Current and Future Analysis for Stand-alone Automation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 23: World Historic Review for Stand-alone Automation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 24: World 15-Year Perspective for Stand-alone Automation by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current and Future Analysis
    • Healthcare Industry Dynamics Augur Well for Lab Automation
    • Table 25: Healthcare Spending as a % of GDP (includes corresponding Graph/Chart)
    • Growing Complexity of Tests Necessitates Automation of Lab Operations
    • Increasing Pressure on Healthcare Organizations Fuels Adoption of Laboratory Automation Systems
    • Shortage of Qualified Lab Workforce: A Major Growth Driver
    • Table 26: Overall Vacancy Rates (%) by Laboratory Departments for the Year 2012 (includes corresponding Graph/Chart)
    • Rising Diagnostic Needs of Aging Population
    • Table 27: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart)
    • Table 28: US Population Breakdown by Age Group (2012) (includes corresponding Graph/Chart)
    • TLA Systems: Improving Quality & Turnaround Times
    • Modular Automation Scores over Total Laboratory Automation Approach
    • Automation Ensures Error-Free and Faster Test Results
    • Regulations Dictate Technological Changes in Laboratories
    • FDA Regulations and Classification of Devices in Clinical Laboratory Automation
    • Product launches
    • Strategic corporate developments
    • Key Players
  • B. Market Analytics
    • Table 29: US Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 30: US Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 31: US 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 32: Canadian Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 33: Canadian Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 34: Canadian 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • Market Analysis
    • Table 35: Japanese Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 36: Japanese Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 37: Japanese 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • European Clinical Diagnostics Automation Market: A Prelude
    • Clinical Diagnostics Market: An Overview
    • Table 38: Diagnostics Market in Europe (2012): Percentage Share Breakdown of Revenues by Medical Imaging, Laboratory Testing, and Anatomic Pathology (includes corresponding Graph/Chart)
    • Debt Crisis in Europe Affects Healthcare Industry
    • Increasing Testing Needs of the Elderly: Business Case for Lab Automation
    • Table 39: Population Breakup by Age Group for Select European Countries: 2012 (As a % of Total Population) (includes corresponding Graph/Chart)
    • Manufacturers Face Significant Challenges
    • Automation Supports Growth in West European IVD Market
  • B. Market Analytics
    • Table 40: European Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 41: European Historic Review for Clinical Diagnostics Automation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 42: European 15-Year Perspective for Clinical Diagnostics Automation by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 43: European Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 44: European Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 45: European 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Key Players
  • B. Market Analytics
    • Table 46: French Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 47: French Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 48: French 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Product Launch
  • B. Market Analytics
    • Table 49: German Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 50: German Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 51: German 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 52: Italian Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 53: Italian Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 54: Italian 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Product launch
  • B. Market Analytics
    • Table 55: UK Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 56: UK Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 57: UK 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 58: Spanish Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 59: Spanish Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 60: Spanish 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 61: Russian Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 62: Russian Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 63: Russian 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Product Launches
    • Strategic corporate development
    • Key Players
  • B. Market Analytics
    • Table 64: Rest of Europe Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 65: Rest of Europe Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 66: Rest of Europe 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Healthcare Spending in Asia-Pacific: On the Rise
  • B. Market Analytics
    • Table 67: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 68: Asia-Pacific Historic Review for Clinical Diagnostics Automation by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 69: Asia-Pacific 15-Year Perspective for Clinical Diagnostics Automation by Geographic Region - Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 70: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 71: Asia-Pacific Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 72: Asia-Pacific 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Outlook
    • Healthcare Reforms: Opportunities for Clinical Labs Market
  • B. Market Analytics
    • Table 73: Chinese Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 74: Chinese Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 75: Chinese 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Automation of Clinical Laboratories on the Rise
    • Challenges Abound in the Indian Clinical Diagnostics Labs Market
    • Private Enterprises Encourage Changes in Diagnostics Sector
    • Indian Blood Gas and Electrolyte Analyzers Market
    • Table 76: Indian Blood Gas and Electrolyte Analyzers and Reagents (2013): Percentage Breakdown of Value and Volume Sales by Segment (includes corresponding Graph/Chart)
      • A List of Key Vendors in the Indian Blood Gas and Electrolyte Analyzers and Reagents Market
    • Product launches
  • B. Market Analytics
    • Table 77: Indian Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 78: Indian Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 79: Indian 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Singapore
  • B. Market Analytics
    • Table 80: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 81: Rest of Asia-Pacific Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 82: Rest of Asia-Pacific 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 83: Latin American Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 84: Latin American Historic Review for Clinical Diagnostics Automation by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 85: Latin American 15-Year Perspective for Clinical Diagnostics Automation by Geographic Region - Percentage Breakdown of Revenues for Brazil and Rest of Latin America Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 86: Latin American Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 87: Latin American Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 88: Latin American 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

6a. BRAZIL

  • A. Market Analysis
    • Outlook
    • Clinical Diagnostics Automation Market Poised to Grow
    • Table 89: Brazilian Clinical Diagnostics Automation Market (2011): Market Share Breakdown by Leading Companies - Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare, and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 90: Brazilian Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 91: Brazilian Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 92: Brazilian 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

6b. REST OF LATIN AMERICA

  • Market Analysis
    • Table 93: Rest of Latin American Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 94: Rest of Latin American Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 95: Rest of Latin American 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Outlook
    • South Africa
      • Major Challenges Impeding Laboratory Automation in Africa
  • B. Market Analytics
    • Table 96: Rest of World Recent Past, Current and Future Analysis for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 97: Rest of World Historic Review for Clinical Diagnostics Automation by Segment - Automated Analyzers, Total Lab Automation and Stand-alone Automation Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 98: Rest of World 15-Year Perspective for Clinical Diagnostics Automation by Segment - Percentage Breakdown of Revenues for Automated Analyzers, Total Lab Automation and Stand-alone Automation for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Back to Top